Talk Bio

Creative Biolabs offers an AI-Driven CAR-T Antibody Engineering Service that uses machine learning and computational biology to optimize scFv sequences with enhanced specificity, affinity, and reduced immunogenicity 1 The AI approach surpasses traditional trial-and-error methods by rapidly analyzing datasets to predict optimal sequences in silico, significantly accelerating design and reducing costs 1 The service addresses CAR-T challenges including T-cell exhaustion and tonic signaling by analyzing existing scFv sequences and proposing targeted modifications to improve cell functionality and persistence 1 Typical CAR-T projects take 10-18 weeks and deliver optimized scFv sequences plus comprehensive functional data from in vitro validation using human primary T cells 1 Creative Biolabs' AI Antibody Humanization Platform transforms animal-derived antibodies into human-like therapeutic candidates while reducing immunogenicity risk and preserving binding affinity 2 The huma...